Chengdu Tetrahedral Drug Research Co. Ltd. has synthesized bicyclic derivatives acting as β-lactamase (bacterial) inhibitors reported to be useful for the treatment of bacterial infection.
GlobalData on MSN1mon
FDA approves AbbVie’s Emblaveo for intra-abdominal infectionsAbbVie has received US Food and Drug Administration (FDA) approval for Emblaveo (aztreonam and avibactam) to be used in ...
BLBLi: β-lactam/β-lactamase inhibitor; CB: Chronic bronchitis ... 250 q.d. × 4 d) A/C (875/125 b.i.d. × 10 d) UC: CC – 93.0 vs 90.1% (NS) G 9 d vs Ceft/Cef 11 d to hospital discharge ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback